For best experience please turn on javascript and use a modern browser!
You are using a browser that is no longer supported by Microsoft. Please upgrade your browser. The site may not present itself correctly if you continue browsing.
Digital development of drug nanocarriers for Alzheimer’s disease
This MMD TechHub project aims to develop the next generation of drug nanocarriers to the brain for Alzheimer’s disease.
The researchers uniquely combine synthetic chemistry, digital tools and in-vivo experiments into an AI-powered feedback loop to develop functionalized drug- and RNA-loaded nanocages targeting Alzheimer's disease.
The UvA uses cookies to measure, optimise, and ensure the proper functioning of the website. Cookies are also placed in order to display third-party content and for marketing purposes. Click 'Accept' to agree to the placement of all cookies; if you only want to accept functional and analytical cookies, select ‘Decline’. You can change your preferences at any time by clicking on 'Cookie settings' at the bottom of each page. Also read the UvA Privacy statement.
